Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

QIAGEN NV buy Morgan Stanley

Start price
€40.47
16.02.24 / 50%
Target price
€47.44
16.02.25
Performance (%)
-
End price
-
17.02.25
Summary
This prediction was cancelled by the user.
Performance without dividends (%)
Name 1w 1m 1y
QIAGEN NV - - -
iShares Core DAX® 0.734% -0.964% 17.910%
iShares Nasdaq 100 -2.686% -2.409% 4.267%
iShares Nikkei 225® -2.261% -4.038% 10.420%
iShares S&P 500 -1.346% -1.510% 1.615%

Comments by Morgan_Stanley for this prediction

In the thread QIAGEN NV diskutieren
Prediction Buy
Perf. (%) -
Target price 47.440
Change
Ends at 16.02.25

Qiagen (NYSE: QGEN) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $51.00 price target on the stock, up previously from $49.48.
Ratings data for QGEN provided by MarketBeat

In the thread Trading QIAGEN NV
Prediction Buy
Perf. (%) -
Target price 47.440
Change
Ends at 16.02.25

Die von Morgan_Stanley gewählte maximale Laufzeit wurde überschritten

Stopped prediction by Morgan_Stanley for QIAGEN NV

buy
QIAGEN NV

Start price
Target price
Perf. (%)
€42.94
23.05.23
-
23.05.24
0.16%
24.05.24